Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Manual for Instructive Application for Youngsters - 27 Extraordinary Efficiency Applications for Experts
- 3Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- 4Northern lights chances rise for Christmas as space weather remains unsettled
- 5Vote In favor of Your Favored Kind Of Organic product
- 'Euphoria' releases Season 3 trailer, premiere date: Watch Rue and Laurie finally face off
- Foot fossil discovery could reshape human evolutionary history
- 6 Exercises to Anticipate in 2024
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- The Way to Monetary Freedom: A Viable Aide
- Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- Language Learning Stages: Which One Gets Your Vote?
- Brazil Passes Law to Use Seized Bitcoin, Crypto to Fund Public Security Measures
- NASA's Artemis astronauts enter final preparations for Moon mission
